Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review

Dihydroartemisinin (DHA), a first-line antimalarial drug, has demonstrated great anticancer effects in many types of tumors, including liver cancer, glioblastoma, and pancreatic cancer. Due to its abilities to induce programmed cell death (PCD; apoptosis, autophagy and ferroptosis), inhibit tumor me...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Ka Hong, Yang, Donglin, Chen, Shanshan, He, Chengwei, Chen, Meiwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459003/
https://www.ncbi.nlm.nih.gov/pubmed/36105316
http://dx.doi.org/10.1016/j.ajps.2022.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459003/
https://www.ncbi.nlm.nih.gov/pubmed/36105316
http://dx.doi.org/10.1016/j.ajps.2022.04.005

Ejemplares similares